This fusion was carried out to exploit the properties of the Secreted Protein Acidic and Rich in Cysteine (SPARC), which is an anti-adhesive and promigratory matricellular glycoprotein that is abundantly expressed in aggressive forms of melanoma, breast, brain, prostate, colon, and lung cancers. The gene discussed is SPARC; the disease is lung cancer.